HER2+ Inflammatory Breast Cancer: Adjuvant Strategies
0 Views
administrator
07/03/23
Debu Tripathy, MD, provides his perspective on delivering appropriate adjuvant therapy given the risk of recurrence in patients with HER2+ inflammatory breast cancer who received surgery.
For more resources and information regarding anticancer targeted therapies: http://targetedonc.com/
-
Category
Show more
Facebook Comments
No comments found